SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for CEL SCI CORP (CVM) (CIK 0000725363) (CVM) — Mar 1, 2012

CEL SCI CORP (CVM) (CIK 0000725363)
Date: March 1, 2012 · CIK: 0000725363 · Accession: 0000000000-12-010853

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-11889

Date
March 1, 2012
Author
Daniel Greenspan
Form
UPLOAD
Company
CEL SCI CORP (CVM) (CIK 0000725363)

Letter

March 1, 2012 Via E-mail Mr. Geert Kersten Chief Executive Officer Cel-Sci Corporation 8229 Boone Blvd., Suite 802 Vienna, VA 22182 Re: Cel-Sci Corporation Schedule 14A Filed February 17, 2012 File No. 001-11889

Dear Mr. Kersten:

We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely,

/s/ Daniel Greenspan for Jeffrey Riedler Assistant Director cc: Patricia B. Prichep Senior Vice President of Operations Cel-Sci Corporation 8229 Boone Blvd., Suite 802 Vienna, VA 22182

Show Raw Text
March 1, 2012
 Via E-mail

Mr. Geert Kersten Chief Executive Officer Cel-Sci Corporation 8229 Boone Blvd., Suite 802 Vienna, VA 22182
Re: Cel-Sci Corporation
  Schedule 14A
Filed February 17, 2012
  File No. 001-11889

Dear Mr. Kersten:

We have completed our review of your f iling.  We remind you that our comments or
changes to disclosure in res ponse to our comments do not for eclose the Commission from taking
any action with respect to the company or th e filing and the company may not assert staff
comments as a defense in any proceeding ini tiated by the Commission or any person under the
federal securities laws of the United States.  We urge all pers ons who are responsible for the
accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.
 Sincerely,

 /s/ Daniel Greenspan for
  Jeffrey Riedler
Assistant Director
 cc: Patricia B. Prichep  Senior Vice President of Operations  Cel-Sci Corporation   8229 Boone Blvd., Suite 802  Vienna, VA 22182